Concepedia
Statistics
Publications
6
Citations
1.2K
H-Index
Active since
2002
Affiliations
Exelixis (United States)(Current)
University of California San Diego
Howard Hughes Medical Institute
University of Virginia Health System
Xalud Therapeutics (United States)
Chris Daige is an author at Exelixis (United States) specializing in lipoprotein metabolism, life sciences, and pharmacology.
Publications per year
2002–2010
Identification of macrophage liver X receptors as inhibitors of atherosclerosis
Rajendra K. Tangirala, Eric D. Bischoff, Sean B. Joseph et al. · Proceedings of the National Academy of Sciences · 2002 · 436 citations
Life Sciences, Molecular Biology, Pharmacology +17
Macrophage Liver X Receptor Is Required for Antiatherogenic Activity of LXR Agonists
Eric D. Bischoff, Chris Daige, Diane Thomas et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2004 · 281 citations
Life Sciences, Cardiology, Pharmacology +17
Promoter-Specific Roles for Liver X Receptor/Corepressor Complexes in the Regulation of ABCA1 and SREBP1 Gene Expression
Brandee Wagner, Annabel F. Valledor, Gang Shao et al. · Molecular and Cellular Biology · 2003 · 238 citations · Full text
Life Sciences, Genetics, Molecular Biology +17
Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR)
Brenton Flatt, Richard Martin, Tielin Wang et al. · Journal of Medicinal Chemistry · 2009 · 161 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Non-redundant roles for LXR and LXR in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice
Eric D. Bischoff, Chris Daige, Mary Petrowski et al. · Journal of Lipid Research · 2010 · 94 citations
Life Sciences, Molecular Biology, Molecular Genetics +14
1–5 of 6